Peripheral neuropathy decisions — 2025

The Board remands the claims for service connection and effective dates due to insufficient evidence of herbicide exposure, and issues related to ratings and TDIU.

The Board granted a rating of 30 percent, but not higher, for peripheral neuropathy of the right upper extremity prior to May 12, 2014; and ratings of 20 percent, but not higher, for peripheral neuropathy of the left upper and lower extremities.

The Veteran's left eye neuropathy was granted a 10% disability rating, and the 100% evaluation for ischemic heart disease (IHD) was restored.

The Board granted service connection for hypertension and peripheral neuropathy of the right and left lower extremities as secondary to the Veteran's service-connected diabetes mellitus type II.

The Board denied earlier effective dates for service connection of neuropathy conditions and hypertension but granted an effective date of October 12, 2022, for a total disability rating based on individual unemployability (TDIU) and Dependents' Educational Assistance.

The Board granted service connection for erectile dysfunction and denied service connection for non-diabetic peripheral neuropathy of both lower extremities, while dismissing the appeals for increased ratings for right shoulder disability and migraines.

The Board denied service connection for all the claimed conditions as there was no competent evidence that any of these disabilities were incurred in or aggravated by active military service.

The Board granted service connection for tinnitus and allergic rhinitis, and assigned ratings of 30 percent for peripheral neuropathy of the radial nerve of the right (dominant) upper extremity, 20 percent for peripheral neuropathy of the median nerve of the left (non-dominant) upper extremity, and 20 percent for peripheral neuropathy of the femoral nerve of both lower extremities. The claims for earlier effective dates were denied.

The Board granted service connection for bilateral feet edema with nerve damage, left and right lower extremity peripheral neuropathy as secondary to diabetes mellitus, type II, but denied the claims for left and right upper extremity peripheral neuropathy.

The Board granted an effective date of July 21, 2017, for the assignment of a 50 percent disability rating for service-connected PTSD and denied higher ratings for right quadriceps disability and left knee degenerative joint disease.

The Board denied a disability rating in excess of 10 percent for painful scars, left tibia ORIF surgery and remanded the issues of entitlement to an initial compensable disability rating for left proximal tibia stress fracture, ankle, with MTSS and unspecified mononeuropathy, left lower extremity, saphenous nerve.

The Board granted service connection for asthma, denied service connection for diabetes mellitus type II, bilateral hands neuropathy, and sleep apnea, and remanded the claims for anxiety and depression.

The Board granted earlier effective dates for the award of service connection for diabetes mellitus, type 2 and its associated complications.

The Board granted a 30 percent disability rating for right and left foot peripheral neuropathy, effective July 1, 2015, as well as a total rating based on individual unemployability from the same date.

The Board granted service connection for bilateral hearing loss and tinnitus, and an initial disability rating of 30 percent for diabetic peripheral neuropathy of the right upper extremity (major). The claim for an increased evaluation for coronary artery disease was remanded.

The Board granted service connection for pseudofolliculitis and bilateral lower extremity peripheral neuropathy, but denied increased ratings for the Veteran's foot, cervical spine, lumbosacral spine, psychiatric disorder, and other conditions.

The Board remands the claims for service connection for right and left hip disabilities, peripheral neuropathy, and bilateral foot pain to correct a duty to assist error in failing to obtain VA examinations and opinions.

The Board granted service connection for diabetes mellitus, type II, as secondary to obstructive sleep apnea and diabetic peripheral neuropathy of the upper and lower extremities, all as secondary to diabetes mellitus, type II.

The Board denied service connection for a skin disability, claimed as chloracne, due to the lack of evidence showing a current diagnosis and no in-service incurrence or aggravation. The claims for right lower extremity (RLE) and left lower extremity (LLE) diabetic peripheral neuropathy were remanded for further development.

The Board remands the issues of entitlement to service connection for various conditions, including diabetes mellitus and peripheral neuropathy, due to a failure to properly consider whether the Veteran established entitlement to a VA medical examination or opinion.